Additionally, the ROR for gastrointestinal disorders caused by Afatinib was significantly higher than that for other EGFR-TKIs, and the ROR for cardiac disorders caused by Osimertinib was markedly higher than that for other EGFR-TKIs. This evidence concerns the gene EGFR and digestive system disorder.